Axiom Investment Management LLC Abb Vie Inc. Transaction History

Axiom Investment Management LLC

$38.4 Million
Q4 2022

A detailed history of Axiom Investment Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Axiom Investment Management LLC holds 8,386 shares of ABBV stock, worth $1.51 Million. This represents 3.53% of its overall portfolio holdings.

Number of Shares

8,386

Previous 7,363 13.89%

Holding current value

$1.51 Million

Previous $988,000 37.25%

% of portfolio

3.53%

Previous 1.98%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $141,491 - $169,685	1,023 Added 13.89%	8,386 $1.36 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $3,086 - $3,540	23 Added 0.31%	7,363 $988,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $2,890 - $3,674	21 Added 0.29%	7,340 $1.12 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $54,111 - $67,137	-410 Reduced 5.3%	7,319 $1.19 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $77,886 - $98,549	-725 Reduced 8.58%	7,729 $1.05 Million
Q3 2021 Oct 18, 2021	BUY	$106.4 - $120.78 $2,766 - $3,140	26 Added 0.31%	8,454 $912,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $470,814 - $524,514	-4,475 Reduced 34.68%	8,428 $949,000
Q1 2021 May 20, 2021	SELL	$102.3 - $112.62 $737,480 - $811,877	-7,209 Reduced 35.84%	12,903 $1.4 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $2 Million - $2.2 Million	19,577 Added 3659.25%	20,112 $2.18 Million
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $729,641 - $985,093	-9,065 Reduced 94.43%	535 $480,000
Q3 2020 Mar 16, 2021	SELL	$85.91 - $100.83 $27,233 - $31,963	-317 Reduced 3.2%	9,600 $841,000
Q2 2020 Mar 16, 2021	BUY	$73.37 - $98.18 $387,833 - $518,979	5,286 Added 114.14%	9,917 $974,000
Q1 2020 Mar 16, 2021	SELL	$64.5 - $97.79 $2,773 - $4,204	-43 Reduced 0.92%	4,631 $353,000
Q4 2019 Mar 16, 2021	SELL	$72.13 - $90.25 $945,263 - $1.18 Million	-13,105 Reduced 73.71%	4,674 $414,000
Q3 2019 Mar 16, 2021	SELL	$62.98 - $75.72 $2.3 Million - $2.77 Million	-36,521 Reduced 67.26%	17,779 $1.35 Million
Q2 2019 Mar 16, 2021	BUY	$65.7 - $83.98 $123,647 - $158,050	1,882 Added 3.59%	54,300 $3.97 Million
Q1 2019 Mar 16, 2021	BUY	$77.14 - $90.79 $228,257 - $268,647	2,959 Added 5.98%	52,418 $4.22 Million
Q4 2018 Oct 23, 2020	BUY	$77.85 - $96.01 $3.85 Million - $4.75 Million	49,459 New	49,459 $4.56 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axiom Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axiom Investment Management LLC with notifications on news.

Account

Axiom Investment Management LLC Abb Vie Inc. Transaction History